Drug alerts › Frusemide Tablets IP 40 mg
Frusemide Tablets IP 40 mg: NSQ and spurious drug alerts
Batches of Frusemide Tablets IP 40 mg listed in CDSCO drug alerts: 2 entries across 2 month(s), from different manufacturers where shown.
Frusemide Tablets IP 40 mg (CareMide Tablets)NSQ
Result: The Sample does not Comply with IP Requirements for the Dissolution Test. The Sample is declared as Misbranded vide Rule 96, Section 17(b) and (c) of Drugs and Cosmetics Act, 1940 and Rules 1945, as the Manufacturer stated Name of Active ingredient as Frusemide tablets IP instead of Frusemide IP on sample Blister and Carton.
Frusemide Tablets IP 40 mgNSQ
Result: The sample does not conform to claim as per IP 2022 in respect to the Test of Dissolution.